Cancer BioBank was established once ICR opened in 1998 by collecting DNA and serum from cancer patients through creation of a network between the institute and the university hospitals. Apart from DNA and serum samples, demographic data of patients have also been filed. 
Read more …


Cancer Immunology


Cancer Immunology research projects were the main line of investigations once ICR was established in 1998. The work group was then extended and physically centralized in an independent laboratory in January 2006 following extension of the physical space of the institute. Read more ...


Cancer Proteomics

To improve our understanding of the proteins that are relevant to the cancer process, Cancer Proteomics Laboratory was established at Shiraz Institute for Cancer Research (ICR) in June 2007. 
Read more ....

Stem Cell

Stem Cell
laboratory was established in Shiraz Institute for Cancer Research in July 2007 after adult mesenchymal stem cells was first isolated and cultured from breast adipose tissue of a patient with breast carcinoma.
Read more ...

Immune Regulation

Immune Regulation lab was established at ICR in 2014. This lab has two distinct lines of research. 1. Investigating the immune regulatory mechanisms in the tumor microenvironment with a focus on B cells. 2. Production of monoclonal antibodies using hybridoma technology. Read more...

Research and Development (R&D)

Research and Development (R&D) laboratory is the affiliation of Shiraz Institute for Cancer Research (ICR) located in the Department of Immunology, Shiraz Medical School. The laboratory started in 2001, and was later expanded in 2005 with the aim to establish a centralized foundation to coordinate research activities and production in the field of human and animal monoclonal antibodies and to step in an expanded scientific and industrial motivation.
ead more….
Shiraz University of Medical Sciences
Shiraz Institute for Cancer Research (ICR)
P.O. Box: 71345-3119
Tel: +98(0)71 32303687
Fax: +98(0)71 32304952